期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

儿童特发性关节炎与巨噬细胞活化综合征 被引量：2

Macrophage Activation Syndrome in Juvenile Idiopathic Arthritis in Children
原文传递
导出
摘要 巨噬细胞活化综合征(MAS)是继发于风湿病的噬血细胞淋巴组织细胞增生症,是儿童特发性关节炎严重的、有生命危险的并发症,其发病机制与穿孔素基因缺陷和自然杀伤细胞功能紊乱有关。及时诊断和治疗是改善MAS预后的关键。现详细介绍MAS的诊断标准以及与全身型儿童特发性关节炎活动期的鉴别诊断。甲泼尼龙静脉冲击疗法、环孢素静脉滴注和丙种球蛋白为主要治疗方法。
作者 程佩萱 胡秀芬
机构地区 华中科技大学同济医学院附属同济医院儿科
出处 《实用儿科临床杂志》 CAS CSCD 北大核心 2009年第21期1631-1633,共3页 Journal of Applied Clinical Pediatrics
关键词 特发性关节炎 巨噬细胞活化综合征 穿孔素 自然杀伤细胞 触发因素 儿童
分类号 R725.9 [医药卫生—儿科]
  • 相关文献

参考文献8

  • 1Kelly A, Ramanan AV. Recognition and management of macrophage activation syndrome in juvenile arthritis[ J]. Curr Opin Rheumatol,2007,19 (5) :477 -481.
  • 2Rramanan AV, Schneider R. Macrophage activation syndrome - What' s in a name[ J]. J Rheumatol,2003,30(12) :2513 -2516.
  • 3Avcin T, Tse SM, Schneider R, et al. Macrophage activation syndrome as the presenting manifestation of rheumatic disease in children [ J]. J Pediatr ,2006 ,148 (5) :683 - 686.
  • 4Stephan JL,Zeller J, Hubert P,et al. Macrophge activation syndrome and rheumatic disease in childhood:A report of four new cases[ J]. Clin Exp Rheumatol, 1993,11 (4) :451 - 456.
  • 5Grom AA. Macrophage activation syndrome and reactive hemophagocytic lymphohistiocytosis: the same entities[ J]. Curr Opin Rheumatol,2003,15(5) :587 -590.
  • 6Ravelli A, Magni - Manzoni S, Pistorio A, et al. Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis [ J ]. J Pediatr ,2005 ,146 (5) :598 - 604.
  • 7Cortis E, Insalaco A. Macrophage activation syndrome in juvenile idiopathic arthritis [ J ]. Acta Pediatrica,2006,95 ( suppl 452) : 38 - 41.
  • 8Stabile A, Bertoni B, Ansuini V, et al. The clinical spectrum and treatment options of macrophage activation syndrome in the pediatric age [ J]. Eu Rev Med Pharmacol Sciences,2006,10( 2 ) :53 - 59.

同被引文献31

  • 1周国平.幼年特发性关节炎的诊断与治疗现状[J].实用儿科临床杂志,2009,24(9):717-720. 被引量：9
  • 2李彩凤,何晓琥,邝伟英,韩彤昕,周怡芳.幼年特发性关节炎全身型并发巨噬细胞活化综合征24例临床分析[J].中华儿科杂志,2006,44(11):806-811. 被引量：23
  • 3Ravelli A, Martini A. Juvenile idiopathic arthritis [ J ]. Lancet, 2007, 369 (9563) : 767 - 778.
  • 4Petty RE, Southwood TR, Baum J, et al. Revision of the proposed classification criteria for juvenile idiopathic arthritis : Durban, 1997 [J]. J Rheumatol,1998,25( 10): 1991 - 1994.
  • 5Foeldvari I, Bidde M. Validation of the proposed ILAR classification criteria for juvenile idiopathic arthritis. International League of Associations for Rheumatology[ J ]. J Rheumatol, 2000,27 ( 4 ) : 1069 - 1072.
  • 6胡亚美,江载芳.幼年类风湿性关节炎[M].第7版.实用儿科学,北京:人民卫生出版社,2002.670.
  • 7McCann LJ, Wedderburn LR, Hasson H. Best Practice: Juvenile idiopathic arthritis [ J ]. Arch Dis Child,2006,91 : 29 - 36.
  • 8Reiff A, Lovell D J, Adelsberg JV. Evaluation of the comparative efficacy and tolerability of rofecoxib and nap roxen in children and adolescents with juvenile rheumatoid arthritis: A12-week randomized controlled clinical trialwith a 52-week open-label extension [ J ]. J Rheumatol,2006,33 ( 5 ) : 985 - 995.
  • 9Puperton N, Nikishina I, Pachanov ED. A randomized, double blind, clinical trim of two doses of meloxicam compared with nap roxen in children with juvenile idiopathic arthritis [ J ]. Arthritis Rheum,2005, 52(2) : 563 -572.
  • 10Ruperto N, Murray K J, Gerloni V. A randomized trial of parenteral methotrexate eompar-ng an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate [ J]. Arthritis Rheum, 2004,50(7 ) : 2191 -2201.

引证文献2

二级引证文献2

实用儿科临床杂志
2009年 第21期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部